Multidrug-ResistantSalmonella entericaSerotype Typhimurium Infections
- 24 September 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (13) , 921-922
- https://doi.org/10.1056/nejm199809243391312
Abstract
Glynn et al. (May 7 issue)1 have shown that infections due to a strain of Salmonella enterica serotype typhimurium, known as definitive type 104 (DT104), that is resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline have increased in the past 15 years in the United States. The authors mention that “no one method . . . is capable of identifying five-drug–resistant typhimurium DT104” and suggest the use of screening “for resistance to chloramphenicol . . . for identifying isolates with the five-drug pattern of resistance.”Keywords
This publication has 7 references indexed in Scilit:
- Emergence of Multidrug-ResistantSalmonella entericaSerotypeTyphimurium DT104 Infections in the United StatesNew England Journal of Medicine, 1998
- Characterisation of integrons and antibiotic resistance genes in Danish multiresistantSalmonella entericaTyphimurium DT104FEMS Microbiology Letters, 1998
- Molecular Epidemiology of Antibiotic Resistance Genes in Multiresistant EpidemicSalmonella typhimuriumDT 104Microbial Drug Resistance, 1998
- Widespread occurrence of integrons causing multiple antibiotic resistance in bacteriaThe Lancet, 1997
- Increasing spectrum of resistance in multiresistant Salmonella typhimuriumThe Lancet, 1996
- Mobile gene cassettes and integrons: capture and spread of genes by site‐specific recombinationMolecular Microbiology, 1995
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994